BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 36 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237,076 | -1.1% | 237,000 | 0.0% | 0.02% | -5.3% |
| Q2 2023 | $239,821 | -3.9% | 237,000 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $249,496 | -2.6% | 237,000 | 0.0% | 0.02% | +18.8% |
| Q4 2022 | $256,234 | +7.7% | 237,000 | 0.0% | 0.02% | +23.1% |
| Q3 2022 | $238,000 | +0.4% | 237,000 | 0.0% | 0.01% | -7.1% |
| Q2 2022 | $237,000 | -92.2% | 237,000 | -91.8% | 0.01% | -93.2% |
| Q4 2021 | $3,022,000 | -83.4% | 2,879,000 | -84.0% | 0.21% | -85.2% |
| Q3 2021 | $18,211,000 | +21.8% | 18,021,000 | +21.6% | 1.39% | +2.3% |
| Q2 2021 | $14,947,000 | – | 14,821,000 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 55,306,226 | $54,866,518 | 2.72% |
| MACKAY SHIELDS LLC | 76,286,000 | $74,883,901 | 2.06% |
| Sonora Investment Management Group, LLC | 10,890,000 | $10,840,075 | 0.93% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 39,812,000 | $39,636,827 | 0.92% |
| BANQUE PICTET & CIE SA | 636,000 | $63,228,545 | 0.75% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,902,000 | $1,884,616 | 0.47% |
| LOOMIS SAYLES & CO L P | 2,074,551 | $183,557 | 0.32% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,015 | 0.28% |
| iA Global Asset Management Inc. | 14,690,000 | $14,625 | 0.24% |
| RATIONAL ADVISORS LLC | 1,803,000 | $1,786,052 | 0.16% |